A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

NCT06572384 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Diseases, Interstitial

Interventions

BIOLOGICAL: Belimumab
OTHER: Placebo

Sponsor

GlaxoSmithKline